| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |